Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Publications

Recent publications published by researchers at the MRC WIMM.

A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses.

Tan TK. et al, (2021), Nat Commun, 12

Lung-targeting lentiviral vector for passive immunisation against influenza

TAN TK. et al, (2020), Thorax

Broadly Inhibiting Antineuraminidase Monoclonal Antibodies Induced by Trivalent Influenza Vaccine and H7N9 Infection in Humans.

Rijal P. et al, (2020), J Virol, 94

Broadly inhibiting anti-neuraminidase monoclonal antibodies induced by 1 trivalent influenza vaccine and H7N9 infection in humans

RIJAL P. and TOWNSEND A., (2019), Journal of Virology

Broadly inhibiting anti-neuraminidase monoclonal antibodies induced by trivalent influenza vaccine and H7N9 infection in humans

RIJAL P. and TOWNSEND A., (2019), Journal of Virology

Therapeutic Monoclonal Antibodies for Ebola Virus Infection Derived from Vaccinated Humans.

Rijal P. et al, (2019), Cell Rep, 27, 172 - 186.e7

A single cycle influenza virus coated in H7 haemagglutinin generates neutralizing antibody responses to haemagglutinin and neuraminidase glycoproteins and protection from heterotypic challenge.

Powell TJ. et al, (2019), J Gen Virol, 100, 431 - 445

Structure-function analysis of neutralizing antibodies to H7N9 influenza from naturally infected humans.

Huang K-YA. et al, (2019), Nat Microbiol, 4, 306 - 315

Characterization of neutralizing epitopes in antigenic site B of recently circulating influenza A(H3N2) viruses.

Beer K. et al, (2018), J Gen Virol, 99, 1001 - 1011

Include forthcoming?